{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:30:00Z","timestamp":1648852200777},"reference-count":5,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2003,5,1]],"date-time":"2003-05-01T00:00:00Z","timestamp":1051747200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Curr Rheumatol Rep"],"published-print":{"date-parts":[[2003,5]]},"DOI":"10.1007\/s11926-003-0069-6","type":"journal-article","created":{"date-parts":[[2007,6,2]],"date-time":"2007-06-02T13:19:38Z","timestamp":1180790378000},"page":"213-214","source":"Crossref","is-referenced-by-count":2,"title":["The case for uricase in gout"],"prefix":"10.1007","volume":"5","author":[{"given":"Salih","family":"Pay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Terkeltaub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"69_CR1","first-page":"967","volume":"19","author":"C-H Pui","year":"2001","unstructured":"Pui C-H, Mahmoud HH, Wiley JM, et al.: Recombinant urate oxidase for the prophylaxis or treatment of hyperuricemia in patients with leukemia or lymphoma. J Clin Oncol 2001, 19:967\u2013704.","journal-title":"J Clin Oncol"},{"key":"69_CR2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0037-1963(01)90038-1","volume":"38","author":"C Patte","year":"2001","unstructured":"Patte C, Sakiroglu O, Sommelet D: European experience in the treatment of hyperuricemia. Semin Hematol 2001, 38(suppl):9\u201312.","journal-title":"Semin Hematol"},{"key":"69_CR3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1053\/shem.2001.29018","volume":"38","author":"C-H Pui","year":"2001","unstructured":"Pui C-H: Urate oxidase in the prophylaxis or treatment of hyperuricemi: the United States experience. Semin Hematol 2001, 38(suppl):13\u201321.","journal-title":"Semin Hematol"},{"key":"69_CR4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0305-7372(02)80004-4","volume":"28","author":"G Molineux","year":"2002","unstructured":"Molineux G: Pegylation: engineering improved pharmaceuticals for enhanced therapy. Cancer Treat Rev 2002, 28(suppl):13\u201316.","journal-title":"Cancer Treat Rev"},{"key":"69_CR5","first-page":"392","volume":"62","author":"S Rozenberg","year":"1995","unstructured":"Rozenberg S, Roche B, Koeger AC, et al.: Urate-oxidase for the treatment of tophaceous gout in heart transplant recipients. Rev Rhum 1995, 62:392\u2013394.","journal-title":"Rev Rhum"}],"container-title":["Current Rheumatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-003-0069-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11926-003-0069-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11926-003-0069-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T00:47:12Z","timestamp":1559436432000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11926-003-0069-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,5]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,5]]}},"alternative-id":["69"],"URL":"https:\/\/doi.org\/10.1007\/s11926-003-0069-6","relation":{},"ISSN":["1523-3774","1534-6307"],"issn-type":[{"value":"1523-3774","type":"print"},{"value":"1534-6307","type":"electronic"}],"subject":[],"published":{"date-parts":[[2003,5]]}}}